GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
last added cars
2022-02-16| Asia-Pacific

Moderna Announces Plan to Set Up Subsidiaries in APAC to Provide mRNA Technology Service

by Aurora Mau
Share To

Moderna, Inc. is one of the most recognized pharmaceutical and biotechnology companies in the world for developing a highly effective vaccine against SARS-CoV-2. With its established subsidiaries in Japan, South Korea, and Australia, the company has announced on February 15 its plan to expand its commercial network across Asia with four new subsidiaries including Taiwan, Malaysia, Singapore, and Hong Kong.

“After a decade of pioneering the development of our mRNA platform, we were ready to play a critical role in combating the COVID-19 pandemic globally,” said Stéphane Bancel, CEO of Moderna. 

Subsidiaries in APAC Will Continue Support mRNA Vaccines and Medications

Moderna’s new subsidiaries will continue to provide local presence to support the delivery of mRNA vaccines and therapeutics.

Bancel further added, “with the addition of four subsidiaries in Asia, we look forward to new opportunities to leverage our mRNA platform to help solve health challenges, including those with a high burden of disease in the Asia-Pacific region.”

Moderna’s Upcoming Development Programs

After developing the second FDA-approved mRNA vaccine against SARS-CoV-2, Moderna continues to upgrade its COVID-19 strategy to combat COVID variants. 

Furthermore, Moderna is also working on mRNA medicines development to prevent and treat diseases with significant unmet needs, including infectious diseases, immuno-oncology, and autoimmune diseases.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Will U.S. ‘s HHS $590 Million Investment Spark a New Era in mRNA Vaccines for Pandemic Flu Threats?
2025-01-22
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
Scroll to Top